About Intellectual Property IP Training Respect for IP IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships AI Tools & Services The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars IP Enforcement WIPO ALERT Raising Awareness World IP Day WIPO Magazine Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Webcast WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO Translate Speech-to-Text Classification Assistant Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight
Arabic English Spanish French Russian Chinese
Laws Treaties Judgments Browse By Jurisdiction

Philippines

PH128

Back

Administrative Order No. 76, Series of 1984, Guidelines to be Observed by FDA (BFAD) in Clearance of Name Relative to Food, Drugs and Cosmetics.

 Microsoft Word - ao 76 s 1984

Republic of the Philippines Ministry of Health

Office of the Minister Manila

January 24, 1984

ADMINISTRATIVE ORDER NO. 76 s. 1984

Subject : Guidelines to be observed by FDA (BFAD) in clearance of name relative to food, drugs and cosmetics.

R.A. 3720 considered a food, drug or cosmetic as misbranded if its labeling is false or misleading in any particular.

For purposes of implementing the misbranding provisions of the “Food, Drug and Cosmetic Act,” the following guidelines with respect to clearance of business name, trade name, brand name, partnership or corporate name or any other similar name or mark appearing in the label of food, drugs and cosmetics shall be observed by the Food and Drug Administration. (Bureau of Food and Drugs)

Section 1. As a general rule, any name which is not yet exclusively appropriated by other person is registrable with FDA (BFAD).

Section 2. The following names cannot be registered with FDA (BFAD):

a) Deceptive name;

b) One resembling another name registered in FDA (BFAD) or previously cleared by it and not abandoned, and likely to cause confusion or mistake or to deceive consumers;

c) One deceptively descriptive, such as most outstanding, the best drug and the like;

d) One geographically descriptive, such as Canadian Food products. This type of name give false impression as to the country of origin of the products.

e) In general rule, one which would confuse the public and unwary consumers and deceive them into believing that the articles bearing one label are similar or produced by the same manufacturer as those carrying the other label.

Section 3. No license to operate a food, drug and cosmetic establishment shall be issued by FDA (BFAD) unless the applied or proposed name is acceptable to FDA (BFAD).

Section 4. No commodity clearance or products registration shall likewise be issued by FDA (BFAD) if the proposed name is one that fall within any of the prohibitions mentioned in Section 2 hereof.

This regulation shall take effect immediately.

(Sgd) CATALINA C. SANCHEZ Director

Approved:

(Sgd) J.C. AZURIN Minister of Health